drugset / Trial / NCT00704249
VENICE Study Nevirapine Full Dose/Dose Escalation
RandomizedParallel-groupOpen-label
Summary
This study aims to compare the trough plasma concentrations of nevirapine after 7 days of treatment at the full dose from baseline with dose escalation in patients taking efavirenz who switch to nevirapine due to neuropsychiatric adverse reactions.
Timeline
- Start
- 2006-07
- Primary completion
- 2008-07
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nevirapine | Small molecule | 200 mg | — |